Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02625610
Title Avelumab in First-Line Gastric Cancer (JAVELIN Gastric 100)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors EMD Serono
Indications
Therapies
Age Groups: adult
Covered Countries USA | TUR | ROU | ITA | HUN | GBR | FRA | ESP | DEU | CAN | BRA | AUS


No variant requirements are available.